Buy
HSBC upgrades Grab to ‘buy’ on attractive valuations, growth drivers ahead
HSBC upgraded its rating on ride-hailing giant Grab to a “buy” on attractive valuations and “intact” growth drivers, while Maybank maintained its buy rating. On Tuesday (Feb 4), its...
CapitaLand Malaysia Trust to buy three freehold industrial properties in Johor-Singapore SEZ for RM72 million
CAPITALAND Malaysia Trust (CLMT), a subsidiary of CapitaLand Investment, on Wednesday (Feb 5) signed a conditional agreement to acquire three freehold industrial properties for a cash consideration of RM72...
Singapore investors buy 6.5 tonnes of gold bars, coins in 2024: World Gold Council
SINGAPORE investors did not shy away from physical gold despite its soaring prices in 2024, leading the demand growth in Asean region with 6.5 tonnes of gold bars and...
Analysts upgrade Frasers Centrepoint Trust to ‘buy’, citing its high retail portfolio occupancy – The Business Times
ANALYSTS have upgraded Frasers Centrepoint Trust (FCT) to a “buy” rating, citing its high retail portfolio occupancy and ongoing asset enhancement initiatives (AEI) as positive signs for its outlook. ...
Saudi prince’s investment firm would be keen on TikTok if Musk or others buy it, CEO says – The Business Times
SAUDI Arabian Prince Alwaleed Bin Talal’s investment company Kingdom Holding (KHC) would be interested in investing in ByteDance’s TikTok if Elon Musk or others offered to buy it, CEO...
Asia looks to buy more US fossil fuels to make Trump happy – The Business Times
ASIAN fossil fuel buyers looking to appease incoming US president Donald Trump have come to the same conclusion: buy more American oil and gas.The re-elected populist leader has threatened...
Honda seeks to buy out Renault’s stake in Nissan, Kyodo reports
HONDA Motor has asked Nissan Motor whether it would be able to acquire Renault’s shareholding, according to a Kyodo News report, as the two Japanese automakers prepare to combine...
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion upfront for IDRx, whose lead...
